Abstract:Importance The overall success rate of circumferential pulmonary vein isolation (CPVI) treatment in patients with paroxysmal atrial fibrillation (AF) remains suboptimal, especially in older patients. Objective To explore the incremental benefit of low-voltage-area ablation after CPVI in older patients with paroxysmal AF. Design, Setting, and Participants This randomized clinical trial was an investigator-initiated trial to compare the efficacy of additional low-voltage-area ablation beyond CPVI vs CPVI alone in older patients with paroxysmal AF. Participants were patients aged 65 to 80 years with paroxysmal AF who were referred for catheter ablation. They were enrolled in 14 tertiary hospitals in China from April 1, 2018, to August 3, 2020, and follow-up occurred through August 15, 2021. Interventions Patients were randomized (1:1) to undergo CPVI plus low-voltage-area ablation or CPVI alone. Low-voltage areas were defined as areas with amplitude less than 0.5 mV in more than 3 adjacent points. If low-voltage areas existed, additional substrate ablation was performed in the CPVI plus group but not the CPVI alone group. Main Outcomes and Measures The primary end point of the study was freedom from atrial tachyarrhythmia as documented by electrocardiogram during a clinical visit or lasting longer than 30 seconds during Holter recordings occurring after a single ablation procedure. Results Among 438 patients who were randomized (mean [SD] age, 70.5 [4.4] years; 219 men [50%]), 24 (5.5%) did not complete the blanking period and were not included for efficacy analysis. After a median follow-up of 23 months, the recurrence rate of atrial tachyarrhythmia was significantly lower in the CPVI plus group (31/209 patients, 15%) compared with the CPVI alone group (49/205, 24%; hazard ratio [HR], 0.61; 95% CI, 0.38-0.95; P = .03). In subgroup analyses, among all patients with low-voltage area, CPVI plus substrate modification was associated with a 51% decreased risk of ATA recurrence compared with CPVI alone (HR, 0.49; 95% CI, 0.25-0.94; P = .03). Conclusions and Relevance This study found that additional low-voltage-area ablation beyond CPVI decreased the ATA recurrence in older patients with paroxysmal AF compared with CPVI alone. Our findings merit further replication by larger trials with longer follow-up. Trial Registration ClinicalTrials.gov Identifier: NCT03462628.

Long-Term Follow-Up Result of Catheter Ablation in Atrial Fibrillation Initiating from Superior Vena Cava

The role of superior vena cava in catheter ablation of long-standing persistent atrial fibrillation.

Pulmonary Vein Isolation Combined With Superior Vena Cava Isolation For Atrial Fibrillation Ablation: A Prospective Randomized Study

Relationship between long‐standing persistent atrial fibrillation and superior vena cava

Circumferential Pulmonary Vein Isolation with Vs Without Additional Low-Voltage-Area Ablation in Older Patients with Paroxysmal Atrial Fibrillation: A Randomized Clinical Trial.

Circumferential Pulmonary Vein Isolation With vs Without Additional Low-Voltage-Area Ablation in Older Patients With Paroxysmal Atrial Fibrillation

Effect of Combined Pulmonary Vein and Superior Vena Cava Isolation on the Outcome of Second Catheter Ablation for Paroxysmal Atrial Fibrillation.

Long-term outcome after successful catheter ablation of atrial fibrillation

Techniques and outcomes of atrial fibrillation ablation in patients with persistent left superior vena cava

Long-term outcomes of catheter ablation of atrial fibrillation post-cardiac valve replacement.

Atrial fibrillation originated from superior vena cava after pulmonary vein ablation

Circumferential Pulmonary Vein Isolation Plus Low-Voltage Area Modification in Persistent Atrial Fibrillation

Anatomical Characteristics of Pulmonary Veins for the Prediction of Postoperative Recurrence after Radiofrequency Catheter Ablation of Atrial Fibrillation.

Comparison of Long-Term Clinical Outcomes Between Segmental and Circumferential Pulmonary Vein Isolation in Patients Undergoing Repeat Atrial Fibrillation Ablation.

Characteristics and Long-Term Ablation Outcomes of Supraventricular Arrhythmias in Hypertrophic Cardiomyopathy: A 10-Year, Single-Center Experience

Effective superior vena cava isolation using a novel C-shaped approach

Repeat Catheter Ablation of Long-Standing Persistent Atrial Fibrillation in Patients with A Total Atrial Fibrillation Duration of More Than 2 Years: Effects of the Cha(2)Ds(2)-Vasc Score and Estimated Glomerular Filtration Rate on the Outcomes

Comparison of Catheter Ablation and Surgical Ablation in Patients with Long-Standing Persistent Atrial Fibrillation and Rheumatic Heart Disease: A Four-Year Follow-Up Study

Superior Vena Cava Isolation With Cryoballoon in AF Ablation: Randomized CAVAC AF Trial

Catheter ablation for atrial fibrillation in patients with persistent left superior vena cava: Case series and systematic review

Comparison Of Empiric Isolation And Conventional Isolation Of Superior Vena Cava In Addition To Pulmonary Vein Isolation On The Outcome Of Paroxysmal Atrial Fibrillation Ablation A Meta-Analysis